Patent details

EP3269363 Title: STABILIZED FORMULATIONS OF CNS COMPOUNDS

Basic Information

Publication number:
EP3269363
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171805765
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABILIZED FORMULATIONS OF CNS COMPOUNDS
French Title of Invention:
FORMULATIONS STABILISÉES DE COMPOSÉS CNS
German Title of Invention:
STABILISIERTE FORMULIERUNGEN AUS CNS-VERBINDUNGEN
SPC Number:

Dates

Filing date:
30/03/2011
Grant date:
28/08/2019
EP Publication Date:
17/01/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/08/2019
EP B1 Publication Date:
28/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/03/2020
Expiration date:
30/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/08/2019
 
 

Name:
Supernus Pharmaceuticals, Inc.
Address:
1550 East Gude Drive, Rockville, MD 20850, United States (US)

Inventor

1

Name:
CHANG, Rong-Kun
Address:
United States (US)

2

Name:
LIANG, Likan
Address:
United States (US)

3

Name:
PATEL, Sachin V.
Address:
United States (US)

4

Name:
BHATT, Padmanabh P.
Address:
United States (US)

5

Name:
VIEIRA, Michael L.
Address:
United States (US)

6

Name:
HUANG, Austin B.
Address:
United States (US)

Priority

Priority Number:
282787 P
Priority Date:
31/03/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/22; A61K 9/52;

Publication

European Patent Bulletin

Issue number:
201935
Publication date:
28/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages